Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lemaitre Vascular (NQ: LMAT )

83.43 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 83.43
Bid (Size) 33.54 (1)
Ask (Size) 132.65 (1)
Prev. Close 83.43
Today's Range 83.43 - 83.43
52wk Range 44.27 - 84.19
Shares Outstanding 22,263,235
Dividend Yield 0.67%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Staar Surgical Stock Earns RS Rating Upgrade
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. 
Via Investor's Business Daily
Navigating 4 Analyst Ratings For LeMaitre Vascular
Via Benzinga

Performance

YTD
+47.12%
+47.12%
1 Month
+7.44%
+7.44%
3 Month
+24.39%
+24.39%
6 Month
+48.93%
+48.93%
1 Year
+31.14%
+31.14%

More News

Read More
Stryker Stock Sees RS Rating Treks Higher To 71
Via Investor's Business Daily
Sell In May And Go Away? – April Dividend Income Report
Via Talk Markets
LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78
Via Investor's Business Daily
Recap: LeMaitre Vascular Q4 Earnings
Via Benzinga
Earnings Scheduled For February 27, 2024
Via Benzinga
A Preview Of LeMaitre Vascular's Earnings
Via Benzinga
5 Analysts Have This to Say About LeMaitre Vascular
Via Benzinga
Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know
Via Benzinga
Sidoti Events, LLC's Virtual December Small-Cap Conference
Via ACCESSWIRE
Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating
Via Benzinga
Looking for Dividend Growth? Buy This Little-Known Healthcare Stock
Via The Motley Fool
2 Healthcare Stocks That Could Help Make You a Fortune
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
Via Benzinga
Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
Via Benzinga
Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
3 Micro-Cap Stocks to Buy Now for Gigantic Growth Potential
Via InvestorPlace
Beat the Dow Jones With This Unstoppable Dividend Stock
Via The Motley Fool
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
Is This Healthcare Stock a Buy for Dividend Growth Investors?
Via The Motley Fool
Why Shares of LeMaitre Vascular Are Up Wednesday
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.